Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Regulus outlines FDA requirements to reinitiate MAD studies with RGLS-4326

July 24, 2019

BioMarin Pharmaceutical identifies hydroxyacid oxidase 1 inhibitors

July 24, 2019

DiaMedica reports phase Ib interim data on DM-199 in chronic kidney disease

June 20, 2019

Arch Biopartners initiates phase I study of Metablok

June 20, 2019

Corvidia opens phase II study of ziltivekimab to reduce inflammation in chronic renal disease

June 14, 2019

RNA triad prevents dialysis-induced fibrosis

June 14, 2019

Increased CCL14 expression linked to chronic kidney disease

June 13, 2019

Positive topline results presented for phase II study of Gazyva in lupus nephritis

June 11, 2019

Goldfinch begins first-in-human study of GFB-887 for kidney disease

June 7, 2019

Allena Pharmaceuticals presents interim results from Study 206 of reloxaliase

June 5, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...